Core Insights - Helus Pharma has appointed Jill Conwell as Chief People Officer, effective immediately, to support the company's growth and clinical programs [1][3][9] Company Overview - Helus Pharma is a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs) aimed at addressing mental health conditions such as depression and anxiety [5][6] - The company is currently advancing its clinical pipeline, including HLP003 in Phase 3 for major depressive disorder and HLP004 in Phase 2 for generalized anxiety disorder [6] Leadership Experience - Jill Conwell brings over 20 years of leadership experience in the life sciences sector, with a strong background in organizational strategy, talent development, and corporate communications [2][4] - Conwell has held senior roles at Aclaris Therapeutics, Idera Pharmaceuticals, and Shire Pharmaceuticals, contributing to organizational growth and transformation [3][4] Strategic Goals - The appointment of Conwell is expected to enhance Helus Pharma's ability to attract top talent and foster a collaborative culture as the company prepares for its next growth phase [3][4] - Conwell expressed enthusiasm about joining Helus Pharma at a critical time, emphasizing the company's innovative approach to mental health treatment [4]